Unilife Corp  

(Public, NASDAQ:UNIS)   Watch this stock  
Find more results for UNIS
2.58
-0.10 (-3.73%)
Jan 18 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.53 - 2.74
52 week 1.58 - 12.90
Open 2.74
Vol / Avg. 132,338.00/100,864.00
Mkt cap 48.27M
P/E     -
Div/yield     -
EPS -6.21
Shares 17.38M
Beta -0.71
Inst. own 15%
Nov 15, 2016
Unilife Corp Annual Shareholders Meeting (Estimated)
Nov 2, 2016
Q3 2016 Unilife Corp Earnings Call - Webcast
Nov 2, 2016
Q3 2016 Unilife Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2016
Net profit margin -1049.21% -679.09%
Operating margin -873.20% -678.77%
EBITD margin - -482.08%
Return on average assets -88.93% -109.51%
Return on average equity - -
Employees 160 -
CDP Score - -

Address

250 Cross Farm Ln
YORK, PA 17406-6200
United States - Map
+1-717-3843400 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Unilife Corporation is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Company has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies. The majority of its products are designed for sale directly to pharmaceutical and biotechnology companies supplying them as drug-device combination products, pre-filled and ready for administration by end-users, such as health-care providers or patients. Its other products, such as reusable auto-injectors and certain systems for targeted drug delivery are designed either to be sold to pharmaceutical or biotechnology companies for use as combination products or to be sold directly to a health care provider or end user without having the device pre-filled by a pharmaceutical company.

Officers and directors

John Ryan J.D. President, Chief Executive Officer, Director
Age: 46
Bio & Compensation  - Reuters
David C. Hastings Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Age: 55
Bio & Compensation  - Reuters
Ian Hanson Chief Operating Officer, Senior Vice President
Age: 42
Bio & Compensation  - Reuters
Stephanie Walters Senior Vice President, General Counsel, Secretary
Bio & Compensation  - Reuters
Kevin Sellers Senior Vice President - Marketing and Communications
Bio & Compensation  - Reuters
Richard L. Beckman M.D. Senior Vice President and Chief Medical Officer
Bio & Compensation  - Reuters
Michael C Ratigan Senior Vice President and Chief Commercial Officer
Bio & Compensation  - Reuters
Molly Weaver Ph.D. Chief Compliance Officer, Vice President - Quality and Regulatory Affairs
Bio & Compensation  - Reuters
Mary Katherine Wold Non-Executive Chairman of the Board, Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
Rosemary A. Crane Director
Age: 56
Bio & Compensation  - Reuters